In this review
The route choice is the distinguishing feature
Nu Image Medical’s peptide menu lists sermorelin injections, rapid-dissolve tablets and nasal spray. [1] That range is the main reason to consider it. Someone who finds injections impractical may value the opportunity to discuss another format. I would keep the clinical question separate from that convenience. The same active name does not establish equivalent exposure, effectiveness or evidence across three routes. The service becomes more useful when the clinician explains those distinctions rather than presenting format choice as a purely cosmetic preference. A reader should know what is being traded as well as what becomes easier.
As low as needs the selected plan
The menu advertises the formats as low as $169 per month. [1] That phrase needs the selected supply and agreement beside it. Ask what qualifies for the lowest rate, the actual amount due now and which visits, laboratory work or delivery charges are included. Confirm whether a longer commitment or larger initial supply is required. I would not assume the same headline means the same preparation, useful duration or payment schedule for every patient. A clear route comparison should also be a clear cost comparison. Otherwise, the apparent simplicity of equal prices can hide meaningful differences in what is supplied.
A needle-free format needs its own evidence
Adult GHRH experiments using an injected preparation do not establish the results of a rapid-dissolve tablet or nasal product. [2] That does not prove a different format can never work; it identifies the evidence that would be needed to support equivalence. Ask whether the service has applicable pharmacokinetic or outcome data for the actual preparation. A tablet dissolving quickly is a practical property, not a demonstrated clinical result. I would give credit to an honest explanation of uncertainty and avoid choosing a route because its name appears beside a familiar injection study. Evidence should follow the formulation being prescribed.
For the relevant study context, see the evidence for oral sermorelin formats.
Compounded status should stay visible
The official peptide page identifies the products as compounded and prescription-only and explains that compounded drugs are not reviewed or approved by the FDA for safety, effectiveness or quality. [1] That is an important part of the product description. A licensed pharmacy and medical evaluation provide accountability, but they do not convert the preparation into an approved finished drug. Ask for the actual dispensing pharmacy, ingredients and label instructions. I would keep those details with the agreement, especially when comparing non-injection formats whose formulation may vary. A broad assurance of professional oversight should not substitute for knowing which preparation is being considered.
Support must match the actual preparation
Nu Image describes provider assessment, delivery and ongoing support. [1] Before enrollment, make the support specific to the selected format: who handles storage or use questions, how a symptom reaches a clinician and how a plan is reconsidered if the expected benefit does not occur. Different delivery methods create different practical questions, so generic customer service is not the complete answer. The agreement should also explain renewal, cancellation and treatment of already prepared medication. I would prefer a clearly supported route with realistic expectations over a more convenient-looking option whose evidence and follow-up remain vague.
My verdict separates convenience from equivalence
Nu Image Medical is a relevant comparison for readers who want to discuss several sermorelin delivery formats under one service. Its limitation is the temptation to treat route choice as evidence-neutral because the advertised starting figure is similar. Compare the actual written plan with another service offering the same route, then examine whether the evidence supports the intended purpose. A favorable purchase would require a clear pharmacy, complete quote and explanation of formulation-specific uncertainty. Convenience can justify interest. It cannot on its own justify assuming a tablet, spray and injection produce the same meaningful clinical result.
A useful alternative is our Sermorelin dot com review; compare the actual purchase rather than the headline alone.
Understanding the cost
Menu advertises formats as low as $169/month. Confirm selected route, amount, qualifying commitment, included care and complete delivered charge. [1]
Build your cost estimateSources
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.